These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 29396014)

  • 21. Peptide selection by MHC-encoded TAP transporters.
    Momburg F; Neefjes JJ; Hämmerling GJ
    Curr Opin Immunol; 1994 Feb; 6(1):32-7. PubMed ID: 8172678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The MHC class I-LILRB1 signalling axis as a promising target in cancer therapy.
    Zhao J; Zhong S; Niu X; Jiang J; Zhang R; Li Q
    Scand J Immunol; 2019 Nov; 90(5):e12804. PubMed ID: 31267559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A structural perspective on MHC class Ib molecules in adaptive immunity.
    Sullivan LC; Hoare HL; McCluskey J; Rossjohn J; Brooks AG
    Trends Immunol; 2006 Sep; 27(9):413-20. PubMed ID: 16860610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides.
    Benichou G; Takizawa PA; Ho PT; Killion CC; Olson CA; McMillan M; Sercarz EE
    J Exp Med; 1990 Nov; 172(5):1341-6. PubMed ID: 1700053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is there MHC Class II restriction of the response to MHC Class I in transplant patients?
    Papassavas AC; Barnardo MC; Bunce M; Welsh KI
    Transplantation; 2002 Feb; 73(4):642-51. PubMed ID: 11889447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the nature of peptides involved in T cell alloreactivity.
    Rötzschke O; Falk K; Faath S; Rammensee HG
    J Exp Med; 1991 Nov; 174(5):1059-71. PubMed ID: 1940788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chicken MHC molecules, disease resistance and the evolutionary origin of birds.
    Kaufman J; Wallny HJ
    Curr Top Microbiol Immunol; 1996; 212():129-41. PubMed ID: 8934816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring synthesis and degradation of MHC class I molecules.
    Guiliano DB; Antoniou AN
    Methods Mol Biol; 2013; 960():93-108. PubMed ID: 23329481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of conserved regions of class I MHC molecules in the activation of CD8+ cytotoxic T lymphocytes by peptide and purified cell-free class I molecules.
    Takeshita T; Kozlowski S; England RD; Brower R; Schneck J; Takahashi H; DeLisi C; Margulies DH; Berzofsky JA
    Int Immunol; 1993 Sep; 5(9):1129-38. PubMed ID: 8241055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unfinished Business: Evolution of the MHC and the Adaptive Immune System of Jawed Vertebrates.
    Kaufman J
    Annu Rev Immunol; 2018 Apr; 36():383-409. PubMed ID: 29677478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MHC class I antigen processing pathways.
    Maffei A; Papadopoulos K; Harris PE
    Hum Immunol; 1997 May; 54(2):91-103. PubMed ID: 9297528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Casting a wider net: Immunosurveillance by nonclassical MHC molecules.
    D'Souza MP; Adams E; Altman JD; Birnbaum ME; Boggiano C; Casorati G; Chien YH; Conley A; Eckle SBG; Früh K; Gondré-Lewis T; Hassan N; Huang H; Jayashankar L; Kasmar AG; Kunwar N; Lavelle J; Lewinsohn DM; Moody B; Picker L; Ramachandra L; Shastri N; Parham P; McMichael AJ; Yewdell JW
    PLoS Pathog; 2019 Feb; 15(2):e1007567. PubMed ID: 30789961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraepithelial lymphocytes and their recognition of non-classical MHC molecules.
    Blumberg RS; Balk SP
    Int Rev Immunol; 1994; 11(1):15-30. PubMed ID: 7520051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of MHC class Ib molecule, H2-M3 in host immunity against tuberculosis.
    Mir SA; Sharma S
    Vaccine; 2013 Aug; 31(37):3818-25. PubMed ID: 23628242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The MHC molecules of nonmammalian vertebrates.
    Kaufman J; Skjoedt K; Salomonsen J
    Immunol Rev; 1990 Feb; 113():83-117. PubMed ID: 2180813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The evolution of alloimmunity and the genesis of adaptive immunity.
    Gould SJ; Hildreth JE; Booth AM
    Q Rev Biol; 2004 Dec; 79(4):359-82. PubMed ID: 15669770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of statistical power as a major limitation in understanding MHC-mediated immunocompetence in wild vertebrate populations.
    Gaigher A; Burri R; San-Jose LM; Roulin A; Fumagalli L
    Mol Ecol; 2019 Dec; 28(23):5115-5132. PubMed ID: 31614047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences.
    Meister GE; Roberts CG; Berzofsky JA; De Groot AS
    Vaccine; 1995 Apr; 13(6):581-91. PubMed ID: 7483779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Invariant Arginine in Common with MHC Class II Allows Extension at the C-Terminal End of Peptides Bound to Chicken MHC Class I.
    Xiao J; Xiang W; Zhang Y; Peng W; Zhao M; Niu L; Chai Y; Qi J; Wang F; Qi P; Pan C; Han L; Wang M; Kaufman J; Gao GF; Liu WJ
    J Immunol; 2018 Nov; 201(10):3084-3095. PubMed ID: 30341185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.